* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Friday, September 26, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    ‘Today’: Sheinelle Jones Thanks Katie Couric for Support After Husband’s Death – CBS 19 News

    Sheinelle Jones Expresses Heartfelt Thanks to Katie Couric for Support After Husband’s Passing

    Sate your hunger at DBA’s Taste of Downtown – Bakersfield.com

    Indulge Your Cravings at DBA’s Taste of Downtown!

    Caesars Entertainment (CZR): Assessing Valuation After Times Square Casino Setback and Mounting Investor Concerns – simplywall.st

    Caesars Entertainment Faces Times Square Casino Hurdles as Investor Concerns Mount

    Why Hilaria Baldwin Has Found the ‘DWTS’ Process ‘Embarrassing’ At Times – WFXG

    Hilaria Baldwin Opens Up About the Embarrassing Moments on Her ‘DWTS’ Journey

    Harvest Fest 2025 – yadkinripple.com

    Celebrate the Bounty: Harvest Fest 2025 is Coming!

    Fox News Entertainment Newsletter: Kate Middleton stuns during Trump state visit, Brett James dead at 57 – Fox News

    Kate Middleton Stuns During Trump State Visit; Remembering Brett James at 57

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

    Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

    What are we really gaining from technology? – Fast Company

    What Are We Really Gaining from Technology?

    TOMI Environmental Solutions, Inc. Expands SteraMist iHP Technology Services in Healthcare Sector with New Provider Partnership – Quiver Quantitative

    TOMI Environmental Solutions Accelerates SteraMist iHP Technology Expansion in Healthcare with New Provider Partnership

    Indiana County Technology Center’s Joint Operating Committee looks to the future as program plans began to take shape – Indiana Gazette Online

    Indiana County Technology Center’s Joint Operating Committee Charts an Exciting Path Forward as New Program Plans Take Shape

    Meta to expand Montgomery data hub, pushing total investment to $1.5 billion – Alabama Department of Commerce

    Meta to Supercharge Montgomery Data Hub with $1.5 Billion Investment

    Agentic AI and the future of work: navigating technological promise and the risk of increased automation – Equal Times

    Agentic AI and the Future of Work: Embracing Innovation While Navigating Automation Challenges

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    ‘Today’: Sheinelle Jones Thanks Katie Couric for Support After Husband’s Death – CBS 19 News

    Sheinelle Jones Expresses Heartfelt Thanks to Katie Couric for Support After Husband’s Passing

    Sate your hunger at DBA’s Taste of Downtown – Bakersfield.com

    Indulge Your Cravings at DBA’s Taste of Downtown!

    Caesars Entertainment (CZR): Assessing Valuation After Times Square Casino Setback and Mounting Investor Concerns – simplywall.st

    Caesars Entertainment Faces Times Square Casino Hurdles as Investor Concerns Mount

    Why Hilaria Baldwin Has Found the ‘DWTS’ Process ‘Embarrassing’ At Times – WFXG

    Hilaria Baldwin Opens Up About the Embarrassing Moments on Her ‘DWTS’ Journey

    Harvest Fest 2025 – yadkinripple.com

    Celebrate the Bounty: Harvest Fest 2025 is Coming!

    Fox News Entertainment Newsletter: Kate Middleton stuns during Trump state visit, Brett James dead at 57 – Fox News

    Kate Middleton Stuns During Trump State Visit; Remembering Brett James at 57

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

    Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

    What are we really gaining from technology? – Fast Company

    What Are We Really Gaining from Technology?

    TOMI Environmental Solutions, Inc. Expands SteraMist iHP Technology Services in Healthcare Sector with New Provider Partnership – Quiver Quantitative

    TOMI Environmental Solutions Accelerates SteraMist iHP Technology Expansion in Healthcare with New Provider Partnership

    Indiana County Technology Center’s Joint Operating Committee looks to the future as program plans began to take shape – Indiana Gazette Online

    Indiana County Technology Center’s Joint Operating Committee Charts an Exciting Path Forward as New Program Plans Take Shape

    Meta to expand Montgomery data hub, pushing total investment to $1.5 billion – Alabama Department of Commerce

    Meta to Supercharge Montgomery Data Hub with $1.5 Billion Investment

    Agentic AI and the future of work: navigating technological promise and the risk of increased automation – Equal Times

    Agentic AI and the Future of Work: Embracing Innovation While Navigating Automation Challenges

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

First-in-Class Antibiotic Effective Against Urogenital Gonorrhea

May 1, 2024
in Health
First-in-Class Antibiotic Effective Against Urogenital Gonorrhea
Share on FacebookShare on Twitter

Gepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of the phase III EAGLE-1 trial.

The microbiological success rate was 92.6% with oral gepotidacin compared with 91.2% with ceftriaxone plus oral azithromycin, reported Jonathan Ross, MD, of the University of Birmingham in England, at the European Society of Clinical Microbiology and Infectious Diseases Global Congress, held this year in Barcelona.

The adjusted treatment difference between the gepotidacin and dual-therapy groups was -0.1% (95% CI -5.6% to 5.5%), falling within prespecified criteria for noninferiority (a lower CI limit above -10.0%). Adverse event (AE) rates, along with drug-related AEs, were higher in the gepotidacin arm.

“There is a need for antibiotics for gonorrhea because the current options we have are very limited,” Ross told MedPage Today. “We have one [oral] antibiotic left — ceftriaxone.”

“We’ve learned over the last 20 to 30 years that we lose antibiotics over time. Already we see signs that sensitivity to ceftriaxone is diminishing,” he said. “Therefore it’s a question of when, rather than if, we lose that last antibiotic.”

Gepotidacin is a first-in-class triazaacenaphthylene, a bactericidal antibiotic that inhibits bacterial DNA replication by blocking two essential topoisomerase enzymes of the Neisseria gonorrhoeae bacterium. Researchers believe that N. gonorrhoeae may be less likely to become resistant to gepotidacin than other antibiotics because mutations in both enzymes would likely be necessary for resistance to develop.

“Multi-drug resistant gonorrhea … is a major public health threat,” Anu Hazra, MD, of Howard Brown Health in Chicago, told MedPage Today. “It may not be at the crosshairs or in the minds of the general public, but for those of us that work in sexual health, it’s something that we are truly concerned about.”

“The challenge with antibiotic development is bacteria become resistant to the antibiotic almost as soon as it is released,” Hazra said. “So I don’t think [gepotidacin] is going to be our stopgap, but at least it might be another tool that we have. I think we need to continue to have a robust drug pipeline to continue to offer us oral agents that will be active against potentially more resistant strains of gonorrhea.”

According to the World Health Organization, in 2020 there were an estimated 82.4 million new gonorrhea infections among adults across the globe. If left untreated, gonorrhea can cause a variety of sexual and reproductive health complications, including infertility in both men and women. It also increases the risk of HIV infection.

Hazra also pointed out that the EAGLE-1 trial only looked at the efficacy of gepotidacin against urogenital gonorrhea. “The major threat that we have with multi-drug resistant gonorrhea has actually been with oropharyngeal gonorrhea,” he said. “So I think this is a great first step, but I will want to see further studies of efficacy of this drug against gonorrhea at other sites as well.”

Ross concurred that more studies of the drug are needed, but noted that it was not the aim of the trial to evaluate gepotidacin in patients with oropharyngeal gonorrhea. However, a small number of patients enrolled in EAGLE-1 also had pharyngeal and/or rectal gonorrheal infections in addition to urogenital infections, he said. All of these patients achieved a microbiologic cure. “I think we can say cautiously that [gepotidacin] seems to work for pharyngeal infections but that’s an important question that remains to be answered,” he said.

Gepotidacin has also been evaluated in the EAGLE-2 and EAGLE-3 trials for efficacy and safety in the treatment of uncomplicated urinary tract infections (UTIs). Those trials found gepotidacin to be noninferior to nitrofurantoin, an antibiotic commonly used as a first-line therapy for the treatment of uncomplicated UTIs.

The current trial included 406 male and female adolescent and adult participants in the primary analysis population with a clinical suspicion of uncomplicated urogenital gonorrhea. Participants were randomized to receive either two 3-g doses of gepotidacin (n=202) or an intramuscular injection of ceftriaxone 500 mg plus 1 g of oral azithromycin (n=204).

The primary endpoint of the trial was microbiological response at a test-of-cure visit 4 to 8 days after treatment. Participants also had a follow-up visit between days 14 to 21 to confirm sustained response to treatment.

Among the study population that underwent microbiological evaluation, of the 7.4% of microbiological failures in the gepotidacin group and the 8.8% in the ceftriaxone/azithromycin group, none of the failures were due to bacteriological persistence. All failures were due to researchers being unable to determine outcomes, for example, in cases where no sample was taken for culture, the sample was lost, or a scheduled visit did not occur.

Among the 622 participants in the safety population — all randomized patients who received at least one dose of study treatment — those who received gepotidacin reported a substantially higher number of AEs than those in the dual therapy arm (519 vs 141 events). Mild-to-moderate gastrointestinal adverse effects — primarily diarrhea — were frequent in the gepotidacin group, Ross said. “That is of concern,” he acknowledged. “It’s hard to get a handle on that until we start using [gepotidacin] in clinical practice — how important is that to patients.”

author['full_name']

Katherine Kahn is a staff writer at MedPage Today, covering the infectious diseases beat. She has been a medical writer for over 15 years.

Disclosures

The study was funded by GSK.

Ross has received consulting fees from GSK and is a shareholder in GSK and AstraZeneca Pharma; several other study co-authors are shareholders and/or employees of GSK.

Hazra reported no relevant financial disclosures.

Primary Source

European Society of Clinical Microbiology and Infectious Diseases

Source Reference: Ross JD, et al “Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea: results of a randomised, multicentre phase 3 trial (EAGLE-1)” ESCMID 2024; Poster LB030.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/infectiousdisease/stds/109902

Tags: AntibioticFirst-in-Classhealth
Previous Post

DEA Will Move to Reclassify Marijuana in Historic Shift, Sources Say

Next Post

Why Don’t Men Have Their Version of ‘The Pill’?

Testing the role of biotic interactions in shaping elevational diversity gradients: An ecological metabolomics approach – ESA Journals

Unraveling How Biotic Interactions Shape Elevational Diversity Gradients Through Ecological Metabolomics

September 26, 2025
Betina Wilkinson elected to American Political Science Association Council – Inside WFU

Betina Wilkinson Joins the Prestigious American Political Science Association Council

September 26, 2025
Dr. STONE SCIENCE FUTURE Cour 3 Anime to Premiere in 2026 – Crunchyroll

Dr. STONE: SCIENCE FUTURE Cour 3 Set to Premiere in 2026!

September 26, 2025
Aldi Just Launched a Huge New Collaboration and It’s Excellent News For Shoppers – Yahoo

Aldi Unveils Exciting New Collaboration That Shoppers Will Love

September 26, 2025
Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

Amazon to Pay $2.5 Billion in Prime Membership Settlement – The New York Times

September 26, 2025
Week 4 NFL against-the-spread picks, predictions for every game: Ravens or Chiefs will be 1-3 – Yahoo Sports

Week 4 NFL Against-the-Spread Picks and Bold Predictions: Will the Ravens or Chiefs Fall to 1-3?

September 25, 2025
Hegseth summons hundreds of top military brass from around the world for mysterious Virginia meeting – AL.com

Hegseth summons hundreds of top military brass from around the world for mysterious Virginia meeting – AL.com

September 25, 2025
US economy expanded at a surprising 3.8% pace in significant upgrade of second quarter growth – News4JAX

US economy expanded at a surprising 3.8% pace in significant upgrade of second quarter growth – News4JAX

September 25, 2025
‘Today’: Sheinelle Jones Thanks Katie Couric for Support After Husband’s Death – CBS 19 News

Sheinelle Jones Expresses Heartfelt Thanks to Katie Couric for Support After Husband’s Passing

September 25, 2025
Private health insurers use AI to approve or deny care. Soon Medicare will, too. – NBC News

Private health insurers use AI to approve or deny care. Soon Medicare will, too. – NBC News

September 25, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (837)
  • Economy (857)
  • Entertainment (21,733)
  • General (17,243)
  • Health (9,900)
  • Lifestyle (870)
  • News (22,149)
  • People (859)
  • Politics (867)
  • Science (16,067)
  • Sports (21,357)
  • Technology (15,840)
  • World (840)

Recent News

Testing the role of biotic interactions in shaping elevational diversity gradients: An ecological metabolomics approach – ESA Journals

Unraveling How Biotic Interactions Shape Elevational Diversity Gradients Through Ecological Metabolomics

September 26, 2025
Betina Wilkinson elected to American Political Science Association Council – Inside WFU

Betina Wilkinson Joins the Prestigious American Political Science Association Council

September 26, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version